Estimating Demand for an HIV Vaccine
Author Information
Author(s): Robert Hecht, Chutima Suraratdecha
Primary Institution: International AIDS Vaccine Initiative
Hypothesis
Reliable estimates of demand for an HIV vaccine are necessary to inform policy and advocacy efforts.
Conclusion
More research is needed to improve estimates of demand for an HIV vaccine to support its eventual introduction.
Supporting Evidence
- About 40 million people worldwide were living with HIV/AIDS at the end of 2005.
- An HIV vaccine could significantly lower the rate of new infections.
- Reliable demand estimates can help persuade governments and industry to invest in vaccine development.
Takeaway
We need to know how many people want an HIV vaccine so we can make sure it's available and affordable when it's ready.
Methodology
The authors reviewed existing scientific literature and synthesized results from 18 previous studies on HIV vaccine demand.
Potential Biases
The stigma associated with HIV/AIDS may lower demand for a vaccine.
Limitations
Existing studies have incomplete estimates and do not reflect current scientific opinion on vaccine characteristics.
Participant Demographics
The studies included various adult populations, including high-risk groups like commercial sex workers and injecting drug users.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website